nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—Vismodegib—skin cancer	0.159	0.21	CbGbCtD
Indacaterol—CYP3A4—Imiquimod—skin cancer	0.137	0.182	CbGbCtD
Indacaterol—CYP3A4—Temozolomide—skin cancer	0.137	0.182	CbGbCtD
Indacaterol—CYP3A4—Vismodegib—skin cancer	0.0952	0.126	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—skin cancer	0.0835	0.11	CbGbCtD
Indacaterol—CYP3A4—Vemurafenib—skin cancer	0.0753	0.0995	CbGbCtD
Indacaterol—ABCB1—Docetaxel—skin cancer	0.0431	0.057	CbGbCtD
Indacaterol—CYP3A4—Docetaxel—skin cancer	0.0258	0.0341	CbGbCtD
Indacaterol—Musculoskeletal pain—Vismodegib—skin cancer	0.00754	0.031	CcSEcCtD
Indacaterol—Hypokalaemia—Vismodegib—skin cancer	0.00492	0.0202	CcSEcCtD
Indacaterol—Musculoskeletal pain—Vemurafenib—skin cancer	0.00466	0.0192	CcSEcCtD
Indacaterol—Connective tissue disorder—Vismodegib—skin cancer	0.00368	0.0151	CcSEcCtD
Indacaterol—Atrial fibrillation—Vemurafenib—skin cancer	0.00352	0.0145	CcSEcCtD
Indacaterol—Malnutrition—Vismodegib—skin cancer	0.00326	0.0134	CcSEcCtD
Indacaterol—Muscle spasms—Vismodegib—skin cancer	0.00313	0.0129	CcSEcCtD
Indacaterol—Atrial fibrillation—Imiquimod—skin cancer	0.00301	0.0124	CcSEcCtD
Indacaterol—Myalgia—Vismodegib—skin cancer	0.00277	0.0114	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00275	0.0113	CcSEcCtD
Indacaterol—Myocardial ischaemia—Fluorouracil—skin cancer	0.0027	0.0111	CcSEcCtD
Indacaterol—Nervous system disorder—Vismodegib—skin cancer	0.00261	0.0107	CcSEcCtD
Indacaterol—Skin disorder—Vismodegib—skin cancer	0.00258	0.0106	CcSEcCtD
Indacaterol—Infestation—Vemurafenib—skin cancer	0.00257	0.0106	CcSEcCtD
Indacaterol—Infestation NOS—Vemurafenib—skin cancer	0.00257	0.0106	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00242	0.00996	CcSEcCtD
Indacaterol—Musculoskeletal pain—Temozolomide—skin cancer	0.00238	0.00979	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vismodegib—skin cancer	0.00229	0.00943	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Imiquimod—skin cancer	0.00229	0.00941	CcSEcCtD
Indacaterol—Oedema peripheral—Vemurafenib—skin cancer	0.00228	0.00936	CcSEcCtD
Indacaterol—Connective tissue disorder—Vemurafenib—skin cancer	0.00227	0.00934	CcSEcCtD
Indacaterol—Infestation NOS—Imiquimod—skin cancer	0.0022	0.00903	CcSEcCtD
Indacaterol—Infestation—Imiquimod—skin cancer	0.0022	0.00903	CcSEcCtD
Indacaterol—Cardiac disorder—Vemurafenib—skin cancer	0.00214	0.00882	CcSEcCtD
Indacaterol—Mediastinal disorder—Vemurafenib—skin cancer	0.00208	0.00856	CcSEcCtD
Indacaterol—Sinusitis—Imiquimod—skin cancer	0.00206	0.00847	CcSEcCtD
Indacaterol—Malnutrition—Vemurafenib—skin cancer	0.00201	0.00827	CcSEcCtD
Indacaterol—Myocardial ischaemia—Docetaxel—skin cancer	0.00195	0.008	CcSEcCtD
Indacaterol—Connective tissue disorder—Imiquimod—skin cancer	0.00194	0.00796	CcSEcCtD
Indacaterol—Rhinorrhoea—Docetaxel—skin cancer	0.00193	0.00794	CcSEcCtD
Indacaterol—Pruritus—Vismodegib—skin cancer	0.00188	0.00773	CcSEcCtD
Indacaterol—Immune system disorder—Imiquimod—skin cancer	0.00178	0.00732	CcSEcCtD
Indacaterol—Mediastinal disorder—Imiquimod—skin cancer	0.00178	0.0073	CcSEcCtD
Indacaterol—Chest discomfort—Docetaxel—skin cancer	0.00177	0.00727	CcSEcCtD
Indacaterol—Cough—Vemurafenib—skin cancer	0.00176	0.00722	CcSEcCtD
Indacaterol—Bronchospasm—Bleomycin—skin cancer	0.00172	0.00708	CcSEcCtD
Indacaterol—Oropharyngeal pain—Docetaxel—skin cancer	0.00172	0.00707	CcSEcCtD
Indacaterol—Malnutrition—Imiquimod—skin cancer	0.00172	0.00705	CcSEcCtD
Indacaterol—Myalgia—Vemurafenib—skin cancer	0.00171	0.00704	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.0017	0.00699	CcSEcCtD
Indacaterol—Rash—Vismodegib—skin cancer	0.00168	0.00689	CcSEcCtD
Indacaterol—Dermatitis—Vismodegib—skin cancer	0.00167	0.00688	CcSEcCtD
Indacaterol—Infection—Vemurafenib—skin cancer	0.00163	0.00671	CcSEcCtD
Indacaterol—Nervous system disorder—Vemurafenib—skin cancer	0.00161	0.00662	CcSEcCtD
Indacaterol—Skin disorder—Vemurafenib—skin cancer	0.00159	0.00656	CcSEcCtD
Indacaterol—Nausea—Vismodegib—skin cancer	0.00158	0.00649	CcSEcCtD
Indacaterol—Pneumonia—Bleomycin—skin cancer	0.00157	0.00645	CcSEcCtD
Indacaterol—Hypokalaemia—Temozolomide—skin cancer	0.00155	0.00639	CcSEcCtD
Indacaterol—Palpitations—Imiquimod—skin cancer	0.00152	0.00623	CcSEcCtD
Indacaterol—Cough—Imiquimod—skin cancer	0.0015	0.00616	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.0015	0.00615	CcSEcCtD
Indacaterol—Pneumonia—Dactinomycin—skin cancer	0.00146	0.00602	CcSEcCtD
Indacaterol—Chest pain—Imiquimod—skin cancer	0.00146	0.00601	CcSEcCtD
Indacaterol—Myalgia—Imiquimod—skin cancer	0.00146	0.00601	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00145	0.00596	CcSEcCtD
Indacaterol—Dry mouth—Imiquimod—skin cancer	0.00143	0.00587	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00142	0.00583	CcSEcCtD
Indacaterol—Nasopharyngitis—Fluorouracil—skin cancer	0.00141	0.00578	CcSEcCtD
Indacaterol—Infection—Imiquimod—skin cancer	0.00139	0.00572	CcSEcCtD
Indacaterol—Nervous system disorder—Imiquimod—skin cancer	0.00137	0.00565	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Temozolomide—skin cancer	0.00137	0.00564	CcSEcCtD
Indacaterol—Tachycardia—Imiquimod—skin cancer	0.00137	0.00562	CcSEcCtD
Indacaterol—Skin disorder—Imiquimod—skin cancer	0.00136	0.00559	CcSEcCtD
Indacaterol—Hyperglycaemia—Temozolomide—skin cancer	0.00133	0.00547	CcSEcCtD
Indacaterol—Angina pectoris—Fluorouracil—skin cancer	0.00132	0.00545	CcSEcCtD
Indacaterol—Pneumonia—Temozolomide—skin cancer	0.00132	0.00544	CcSEcCtD
Indacaterol—Infestation—Temozolomide—skin cancer	0.00132	0.00541	CcSEcCtD
Indacaterol—Infestation NOS—Temozolomide—skin cancer	0.00132	0.00541	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00128	0.00525	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00126	0.0052	CcSEcCtD
Indacaterol—Paraesthesia—Imiquimod—skin cancer	0.00126	0.00517	CcSEcCtD
Indacaterol—Dyspnoea—Imiquimod—skin cancer	0.00125	0.00513	CcSEcCtD
Indacaterol—Sinusitis—Temozolomide—skin cancer	0.00123	0.00508	CcSEcCtD
Indacaterol—Pneumonia—Fluorouracil—skin cancer	0.00122	0.00501	CcSEcCtD
Indacaterol—Infestation NOS—Fluorouracil—skin cancer	0.00121	0.00498	CcSEcCtD
Indacaterol—Infestation—Fluorouracil—skin cancer	0.00121	0.00498	CcSEcCtD
Indacaterol—Hypersensitivity—Vemurafenib—skin cancer	0.00121	0.00497	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Imiquimod—skin cancer	0.00121	0.00497	CcSEcCtD
Indacaterol—Atrial fibrillation—Docetaxel—skin cancer	0.0012	0.00493	CcSEcCtD
Indacaterol—Oedema peripheral—Temozolomide—skin cancer	0.00116	0.00478	CcSEcCtD
Indacaterol—Pruritus—Vemurafenib—skin cancer	0.00116	0.00478	CcSEcCtD
Indacaterol—Connective tissue disorder—Temozolomide—skin cancer	0.00116	0.00477	CcSEcCtD
Indacaterol—Sinusitis—Fluorouracil—skin cancer	0.00114	0.00468	CcSEcCtD
Indacaterol—Anaemia—Bleomycin—skin cancer	0.00113	0.00463	CcSEcCtD
Indacaterol—Cardiac disorder—Temozolomide—skin cancer	0.0011	0.00451	CcSEcCtD
Indacaterol—Dizziness—Vemurafenib—skin cancer	0.00109	0.00446	CcSEcCtD
Indacaterol—Immune system disorder—Temozolomide—skin cancer	0.00107	0.00439	CcSEcCtD
Indacaterol—Mediastinal disorder—Temozolomide—skin cancer	0.00106	0.00438	CcSEcCtD
Indacaterol—Cough—Bleomycin—skin cancer	0.00106	0.00437	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—skin cancer	0.00105	0.00432	CcSEcCtD
Indacaterol—Myalgia—Bleomycin—skin cancer	0.00104	0.00427	CcSEcCtD
Indacaterol—Chest pain—Bleomycin—skin cancer	0.00104	0.00427	CcSEcCtD
Indacaterol—Rash—Vemurafenib—skin cancer	0.00104	0.00426	CcSEcCtD
Indacaterol—Dermatitis—Vemurafenib—skin cancer	0.00103	0.00425	CcSEcCtD
Indacaterol—Hypersensitivity—Imiquimod—skin cancer	0.00103	0.00424	CcSEcCtD
Indacaterol—Headache—Vemurafenib—skin cancer	0.00103	0.00423	CcSEcCtD
Indacaterol—Malnutrition—Temozolomide—skin cancer	0.00103	0.00423	CcSEcCtD
Indacaterol—Nasopharyngitis—Docetaxel—skin cancer	0.00102	0.00417	CcSEcCtD
Indacaterol—Pruritus—Imiquimod—skin cancer	0.000991	0.00407	CcSEcCtD
Indacaterol—Infection—Bleomycin—skin cancer	0.000988	0.00406	CcSEcCtD
Indacaterol—Nausea—Vemurafenib—skin cancer	0.000975	0.00401	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—skin cancer	0.000968	0.00398	CcSEcCtD
Indacaterol—Bronchospasm—Docetaxel—skin cancer	0.000965	0.00397	CcSEcCtD
Indacaterol—Tremor—Temozolomide—skin cancer	0.000963	0.00396	CcSEcCtD
Indacaterol—Angina pectoris—Docetaxel—skin cancer	0.000956	0.00393	CcSEcCtD
Indacaterol—Anaemia—Temozolomide—skin cancer	0.00095	0.00391	CcSEcCtD
Indacaterol—Dizziness—Imiquimod—skin cancer	0.000926	0.00381	CcSEcCtD
Indacaterol—Vertigo—Temozolomide—skin cancer	0.000924	0.0038	CcSEcCtD
Indacaterol—Infection—Dactinomycin—skin cancer	0.000922	0.00379	CcSEcCtD
Indacaterol—Palpitations—Temozolomide—skin cancer	0.000909	0.00374	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000906	0.00373	CcSEcCtD
Indacaterol—Cough—Temozolomide—skin cancer	0.000897	0.00369	CcSEcCtD
Indacaterol—Paraesthesia—Bleomycin—skin cancer	0.000893	0.00367	CcSEcCtD
Indacaterol—Dyspnoea—Bleomycin—skin cancer	0.000887	0.00365	CcSEcCtD
Indacaterol—Rash—Imiquimod—skin cancer	0.000883	0.00363	CcSEcCtD
Indacaterol—Dermatitis—Imiquimod—skin cancer	0.000882	0.00363	CcSEcCtD
Indacaterol—Pneumonia—Docetaxel—skin cancer	0.00088	0.00362	CcSEcCtD
Indacaterol—Headache—Imiquimod—skin cancer	0.000877	0.00361	CcSEcCtD
Indacaterol—Anaemia—Fluorouracil—skin cancer	0.000876	0.0036	CcSEcCtD
Indacaterol—Myalgia—Temozolomide—skin cancer	0.000875	0.0036	CcSEcCtD
Indacaterol—Infestation NOS—Docetaxel—skin cancer	0.000875	0.0036	CcSEcCtD
Indacaterol—Infestation—Docetaxel—skin cancer	0.000875	0.0036	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000869	0.00357	CcSEcCtD
Indacaterol—Dry mouth—Temozolomide—skin cancer	0.000856	0.00352	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000845	0.00348	CcSEcCtD
Indacaterol—Infection—Temozolomide—skin cancer	0.000834	0.00343	CcSEcCtD
Indacaterol—Nausea—Imiquimod—skin cancer	0.000832	0.00342	CcSEcCtD
Indacaterol—Nervous system disorder—Temozolomide—skin cancer	0.000823	0.00338	CcSEcCtD
Indacaterol—Skin disorder—Temozolomide—skin cancer	0.000815	0.00335	CcSEcCtD
Indacaterol—Chest pain—Fluorouracil—skin cancer	0.000806	0.00332	CcSEcCtD
Indacaterol—Myalgia—Fluorouracil—skin cancer	0.000806	0.00332	CcSEcCtD
Indacaterol—Oedema peripheral—Docetaxel—skin cancer	0.000774	0.00318	CcSEcCtD
Indacaterol—Connective tissue disorder—Docetaxel—skin cancer	0.000772	0.00317	CcSEcCtD
Indacaterol—Infection—Fluorouracil—skin cancer	0.000768	0.00316	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000764	0.00314	CcSEcCtD
Indacaterol—Nervous system disorder—Fluorouracil—skin cancer	0.000758	0.00312	CcSEcCtD
Indacaterol—Tachycardia—Fluorouracil—skin cancer	0.000755	0.0031	CcSEcCtD
Indacaterol—Paraesthesia—Temozolomide—skin cancer	0.000753	0.0031	CcSEcCtD
Indacaterol—Dyspnoea—Temozolomide—skin cancer	0.000748	0.00308	CcSEcCtD
Indacaterol—Hypersensitivity—Bleomycin—skin cancer	0.000733	0.00301	CcSEcCtD
Indacaterol—Cardiac disorder—Docetaxel—skin cancer	0.000729	0.003	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000724	0.00298	CcSEcCtD
Indacaterol—Immune system disorder—Docetaxel—skin cancer	0.000709	0.00292	CcSEcCtD
Indacaterol—Mediastinal disorder—Docetaxel—skin cancer	0.000708	0.00291	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000704	0.0029	CcSEcCtD
Indacaterol—Pruritus—Bleomycin—skin cancer	0.000704	0.00289	CcSEcCtD
Indacaterol—Paraesthesia—Fluorouracil—skin cancer	0.000694	0.00285	CcSEcCtD
Indacaterol—Dyspnoea—Fluorouracil—skin cancer	0.000689	0.00283	CcSEcCtD
Indacaterol—Malnutrition—Docetaxel—skin cancer	0.000684	0.00281	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—skin cancer	0.000683	0.00281	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000667	0.00274	CcSEcCtD
Indacaterol—Muscle spasms—Docetaxel—skin cancer	0.000657	0.0027	CcSEcCtD
Indacaterol—Anaemia—Docetaxel—skin cancer	0.000632	0.0026	CcSEcCtD
Indacaterol—Rash—Bleomycin—skin cancer	0.000627	0.00258	CcSEcCtD
Indacaterol—Dermatitis—Bleomycin—skin cancer	0.000627	0.00258	CcSEcCtD
Indacaterol—Hypersensitivity—Temozolomide—skin cancer	0.000618	0.00254	CcSEcCtD
Indacaterol—Palpitations—Docetaxel—skin cancer	0.000604	0.00248	CcSEcCtD
Indacaterol—Cough—Docetaxel—skin cancer	0.000597	0.00245	CcSEcCtD
Indacaterol—Pruritus—Temozolomide—skin cancer	0.000594	0.00244	CcSEcCtD
Indacaterol—Nausea—Bleomycin—skin cancer	0.000591	0.00243	CcSEcCtD
Indacaterol—Rash—Dactinomycin—skin cancer	0.000585	0.00241	CcSEcCtD
Indacaterol—Chest pain—Docetaxel—skin cancer	0.000582	0.00239	CcSEcCtD
Indacaterol—Myalgia—Docetaxel—skin cancer	0.000582	0.00239	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000578	0.00238	CcSEcCtD
Indacaterol—Hypersensitivity—Fluorouracil—skin cancer	0.00057	0.00234	CcSEcCtD
Indacaterol—Dry mouth—Docetaxel—skin cancer	0.000569	0.00234	CcSEcCtD
Indacaterol—Dizziness—Temozolomide—skin cancer	0.000555	0.00228	CcSEcCtD
Indacaterol—Infection—Docetaxel—skin cancer	0.000554	0.00228	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—skin cancer	0.000551	0.00227	CcSEcCtD
Indacaterol—Nervous system disorder—Docetaxel—skin cancer	0.000547	0.00225	CcSEcCtD
Indacaterol—Pruritus—Fluorouracil—skin cancer	0.000547	0.00225	CcSEcCtD
Indacaterol—Tachycardia—Docetaxel—skin cancer	0.000545	0.00224	CcSEcCtD
Indacaterol—Skin disorder—Docetaxel—skin cancer	0.000542	0.00223	CcSEcCtD
Indacaterol—Rash—Temozolomide—skin cancer	0.000529	0.00218	CcSEcCtD
Indacaterol—Dermatitis—Temozolomide—skin cancer	0.000529	0.00217	CcSEcCtD
Indacaterol—Headache—Temozolomide—skin cancer	0.000526	0.00216	CcSEcCtD
Indacaterol—Dizziness—Fluorouracil—skin cancer	0.000511	0.0021	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000508	0.00209	CcSEcCtD
Indacaterol—Paraesthesia—Docetaxel—skin cancer	0.000501	0.00206	CcSEcCtD
Indacaterol—Nausea—Temozolomide—skin cancer	0.000498	0.00205	CcSEcCtD
Indacaterol—Dyspnoea—Docetaxel—skin cancer	0.000497	0.00205	CcSEcCtD
Indacaterol—Rash—Fluorouracil—skin cancer	0.000487	0.002	CcSEcCtD
Indacaterol—Dermatitis—Fluorouracil—skin cancer	0.000487	0.002	CcSEcCtD
Indacaterol—Headache—Fluorouracil—skin cancer	0.000484	0.00199	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000482	0.00198	CcSEcCtD
Indacaterol—Nausea—Fluorouracil—skin cancer	0.000459	0.00189	CcSEcCtD
Indacaterol—Hypersensitivity—Docetaxel—skin cancer	0.000411	0.00169	CcSEcCtD
Indacaterol—Pruritus—Docetaxel—skin cancer	0.000395	0.00162	CcSEcCtD
Indacaterol—Dizziness—Docetaxel—skin cancer	0.000369	0.00152	CcSEcCtD
Indacaterol—Rash—Docetaxel—skin cancer	0.000352	0.00145	CcSEcCtD
Indacaterol—Dermatitis—Docetaxel—skin cancer	0.000351	0.00145	CcSEcCtD
Indacaterol—Headache—Docetaxel—skin cancer	0.00035	0.00144	CcSEcCtD
Indacaterol—Nausea—Docetaxel—skin cancer	0.000331	0.00136	CcSEcCtD
